Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Sapient Capital LLC

Sapient Capital LLC trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.6% during the fourth quarter, HoldingsChannel.com reports. The fund owned 97,111 shares of the medical equipment provider’s stock after selling 625 shares during the period. Intuitive Surgical makes up approximately 1.0% of Sapient Capital LLC’s holdings, making the stock its 20th largest holding. Sapient Capital LLC’s holdings in Intuitive Surgical were worth $50,688,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of ISRG. Thurston Springer Miller Herd & Titak Inc. grew its holdings in shares of Intuitive Surgical by 19.1% during the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,158 shares of the medical equipment provider’s stock worth $569,000 after buying an additional 186 shares during the last quarter. Procyon Advisors LLC lifted its holdings in shares of Intuitive Surgical by 4.1% during the third quarter. Procyon Advisors LLC now owns 6,257 shares of the medical equipment provider’s stock worth $3,071,000 after purchasing an additional 248 shares during the period. ORG Wealth Partners LLC purchased a new position in Intuitive Surgical in the 3rd quarter valued at $65,000. Affinity Wealth Management LLC acquired a new position in Intuitive Surgical in the 3rd quarter valued at $3,445,000. Finally, Fiduciary Alliance LLC purchased a new position in Intuitive Surgical during the 3rd quarter worth $4,591,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several analyst reports. Royal Bank of Canada lifted their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. JPMorgan Chase & Co. boosted their target price on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. CICC Research started coverage on Intuitive Surgical in a report on Monday, January 27th. They issued a “neutral” rating and a $550.00 price target for the company. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a report on Friday, October 18th. Finally, Evercore ISI raised their target price on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Jamie Samath sold 269 shares of the stock in a transaction on Monday, February 10th. The stock was sold at an average price of $590.00, for a total value of $158,710.00. Following the transaction, the chief financial officer now directly owns 3,282 shares in the company, valued at approximately $1,936,380. This represents a 7.58 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 5,940 shares of company stock valued at $3,346,964 over the last quarter. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $595.70 on Tuesday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The company has a market capitalization of $212.18 billion, a price-to-earnings ratio of 92.93, a PEG ratio of 5.67 and a beta of 1.39. The stock has a fifty day moving average of $554.85 and a two-hundred day moving average of $514.80.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.